My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Voyager Therapeutics, Inc. - Common Stock (NQ:VYGR)

3.390 -0.030 (-0.88%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Voyager Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

The Jobs Report and Other Stock Market News ↗

October 29, 2021

What's been going on?

Via The Motley Fool

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 21, 2021

Gainers Sio Gene Therapies (NASDAQ:SIOX) stock moved upwards by 22.79% to $2.64 during Thursday's regular session. The current volume of 17.1 million shares is 2411.03...

Via Benzinga

Top 10 DeFi Projects To Watch In 2022 ↗

October 20, 2021

By Voyager's Charlotte Siller, provided exclusive...

Via Benzinga

Voyager Posts Encouraging Preclinical Data For CNS-Directed Gene Therapy ↗

October 20, 2021

Voyager Therapeutics Inc (NASDAQ: VYGR) has announced the presentation of preclinical data of GBA1 gene replacement therapy. The data demonstrated that a single...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 18, 2021

Gainers Dermata Therapeutics (NASDAQ:DRMA

Via Benzinga

46 Biggest Movers From Yesterday ↗

October 12, 2021

Gainers Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares jumped 93.9% to close at $35.36 on Monday. The FDA removed the full clinical hold on Protagonist Therapeutics’...

Via Benzinga

Mid-Afternoon Market Update: Dow Tumbles Over 100 Points; Flexion Therapeutics Shares Spike Higher ↗

October 11, 2021

Toward the end of trading on Monday, the Dow traded down 0.37% to 34,617.17 while the Nasdaq fell 0.05% to 34,617.14. The S&P 500 also fell, dropping 0.26% to 4,379.88. Let's look at what has happened...

Via Talk Markets

Topics Stocks

Mid-Afternoon Market Update: Dow Tumbles Over 100 Points; Flexion Therapeutics Shares Spike Higher ↗

October 11, 2021

Toward the end of trading Monday, the Dow traded down 0.37% to 34,617.17 while the NASDAQ fell 0.05% to 34,617.14. The S&P also fell, dropping 0.26% to 4,379.88. The U.S. has...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 11, 2021

Gainers Protagonist Therapeutics (NASDAQ:PTGX) shares increased by 92.43% to $35.1 during Monday's regular session. Trading volume for this security as of 12:30 EST is...

Via Benzinga

Mid-Day Market Update: Crude Oil Surges Over 2%; Supernus Pharmaceuticals To Acquire Adamas Pharmaceuticals ↗

October 11, 2021

Midway through trading Monday, the Dow traded up 0.50% to 34,920.55 while the NASDAQ rose 0.50% to 34,920.55. The S&P also rose, gaining 0.44% to 4,410.73. The U.S. has the...

Via Benzinga

Topics Stocks

28 Stocks Moving In Monday's Mid-Day Session ↗

October 11, 2021

Gainers Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares surged 85% to $33.78. The FDA removed the full clinical hold on Protagonist Therapeutics’ rusfertide clinical...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 11, 2021

Gainers Protagonist Therapeutics (NASDAQ:PTGX) shares moved upwards by 89.3% to $34.53 during Monday's pre-market session. The market value of their outstanding shares is at...

Via Benzinga

35 Biggest Movers From Friday ↗

October 11, 2021

Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) shares surged 96% to close at $38.41 on Friday. The FDA approved ChemoCentryx’s Tavneos (avacopan) as an adjunctive treatment for...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 08, 2021

Gainers ChemoCentryx (NASDAQ:CCXI) stock increased by 70.43% to $33.41 during Friday's regular session. As of 12:30 EST, this security is trading at a volume of 74.6...

Via Benzinga

Everything You Need To Know To Get Into DeFi ↗

October 07, 2021

DeFi assets are getting a lot of recent attention from investors as they change the way we do business and take crypto transactions to the next fro...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2021 ↗

October 07, 2021

Upgrades For State Street Corporation (NYSE:

Via Benzinga

40 Biggest Movers From Yesterday ↗

October 07, 2021

Gainers Volcon, Inc. (NASDAQ: VLCN) shares jumped 97.5% to settle at $10.86 on Wednesday as the company priced its IPO at $5.50 per share. Voyager Therapeutics, Inc. (NASDAQ:...

Via Benzinga

Topics Initial Public Offering

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 06, 2021

Gainers TransCode Therapeutics (NASDAQ:RNAZ

Via Benzinga

Mid-Afternoon Market Update: US Stocks Turn Positive; Hovnanian Enterprises Shares Slide ↗

October 06, 2021

Toward the end of trading Wednesday, the Dow traded up 0.08% to 34,342.65 while the NASDAQ rose 0.38% to 14,489.14. The S&P also rose, gaining 0.19% to 4,353.99. The U.S. has...

Via Benzinga

Topics Stocks

VYGR Stock: The Huge Licensing Deal Sending Voyager Therapeutics Rocketing Higher ↗

October 06, 2021

Here's the big licensing news that's sending shares of VYGR stock higher today as investors reassess this company's value moving forward.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 06, 2021

Gainers Voyager Therapeutics (NASDAQ:VYGR) shares moved upwards by 44.73% to $3.58 during Wednesday's regular session. Voyager Therapeutics's stock is trading at a...

Via Benzinga

Mid-Day Market Update: Dow Tumbles Over 300 Points; Acer Therapeutics Shares Jump ↗

October 06, 2021

Midway through trading Wednesday, the Dow traded down 0.92% to 33,997.95 while the NASDAQ fell 0.49% to 14,362.47. The S&P also fell, dropping 0.75% to 4,313.33. The U.S. has...

Via Benzinga

Topics Stocks

26 Stocks Moving In Wednesday's Mid-Day Session ↗

October 06, 2021

Gainers Voyager Therapeutics, Inc. (NASDAQ: VYGR) shares jumped 54.1% to $3.8050 after the company announced licensing option agreement with Pfizer for capsids generated from...

Via Benzinga

Mid-Morning Market Update: Markets Open Lower; Acuity Brands Posts Upbeat Q4 Results ↗

October 06, 2021

Following the market opening Wednesday, the Dow traded down 1.12% to 33,929.34 while the NASDAQ fell 0.69% to 14,334.78. The S&P also fell, dropping 0.90% to 4,306.41. The U.S...

Via Benzinga

Topics Stocks

Voyager Therapeutics Stock Soars On License Option Pact With Pfizer ↗

October 06, 2021

Voyager Therapeutics Inc (NASDAQ: VYGR) has announced licensing option agreement with Pfizer Inc (NYSE: PFE) for capsids generated from Voyager's RNA...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 06, 2021

Gainers Voyager Therapeutics (NASDAQ:VYGR) shares increased by 46.15% to $3.61 during Wednesday's pre-market session. The company's market cap stands at $136.9...

Via Benzinga

5 Gene Therapy Stocks Back in Focus on AbbVie/Regenxbio Deal ↗

September 14, 2021

Gene therapy is set to become one of the most vital spaces with high prospects in the biotech sector.

Via Talk Markets

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal ↗

October 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (...

Via Benzinga

The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO ↗

October 01, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks...

Via Benzinga

The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug ↗

September 30, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Acceleron Pharma Inc. (...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.